GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » Shiller PE Ratio

Mochida Pharmaceutical Co (TSE:4534) Shiller PE Ratio : 14.58 (As of May. 15, 2024)


View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-15), Mochida Pharmaceutical Co's current share price is 円3120.00. Mochida Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 was 円214.03. Mochida Pharmaceutical Co's Shiller PE Ratio for today is 14.58.

The historical rank and industry rank for Mochida Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

TSE:4534' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.9   Med: 16.98   Max: 27.34
Current: 15.09

During the past years, Mochida Pharmaceutical Co's highest Shiller PE Ratio was 27.34. The lowest was 13.90. And the median was 16.98.

TSE:4534's Shiller PE Ratio is ranked better than
75.28% of 534 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs TSE:4534: 15.09

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was 円45.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is 円214.03 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mochida Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Mochida Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co Shiller PE Ratio Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.54 20.24 17.02 15.18 -

Mochida Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.18 14.88 15.18 15.28 -

Competitive Comparison of Mochida Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.



Mochida Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=3120.00/214.03
=14.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=45.09/106.8000*106.8000
=45.090

Current CPI (Dec. 2023) = 106.8000.

Mochida Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 34.557 95.700 38.565
201406 47.825 98.000 52.119
201409 29.290 98.500 31.758
201412 85.050 97.900 92.782
201503 26.460 97.900 28.865
201506 80.555 98.400 87.432
201509 40.685 98.500 44.113
201512 90.206 98.100 98.206
201603 -6.245 97.900 -6.813
201606 82.480 98.100 89.795
201609 57.590 98.000 62.761
201612 106.592 98.400 115.691
201703 -31.958 98.100 -34.792
201706 108.770 98.500 117.935
201709 40.395 98.800 43.666
201712 84.315 99.400 90.592
201803 -6.221 99.200 -6.698
201806 147.190 99.200 158.467
201809 27.510 99.900 29.410
201812 73.373 99.700 78.598
201903 -36.044 99.700 -38.611
201906 84.250 99.800 90.159
201909 32.807 100.100 35.003
201912 45.670 100.500 48.533
202003 -45.931 100.300 -48.908
202006 86.890 99.900 92.891
202009 52.740 99.900 56.383
202012 77.560 99.300 83.418
202103 4.703 99.900 5.028
202106 69.350 99.500 74.438
202109 59.120 100.100 63.077
202112 137.820 100.100 147.045
202203 10.354 101.100 10.938
202206 83.980 101.800 88.105
202209 20.593 103.100 21.332
202212 111.850 104.100 114.751
202303 -39.197 104.400 -40.098
202306 46.240 105.200 46.943
202309 32.150 106.200 32.332
202312 45.090 106.800 45.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mochida Pharmaceutical Co  (TSE:4534) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mochida Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mochida Pharmaceutical Co (TSE:4534) Business Description

Traded in Other Exchanges
N/A
Address
1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines